Browse All Treatments

Showing 1856 records.


Page 65 of 186 1 63 64 65 66 67 186
Order by:
SurvivalPatientsToxicityTreatmentHospitalCountryDate
64115.6 monthsAdvanced colorectal cancer4ChemotherapyHospital La PazSpainApr 2004
Treatment Details: Patients: This Phase II study involved 91 patients with advanced colorectal cancer. Treatment: The treatment consisted of two chemotherapy drugs – irinotecan (camptosar, CPT-11)... read more
64215.6 monthsAdvanced colorectal cancer4ChemotherapyHospital La PazSpainApr 2004
Treatment Details: Patients: This Phase II study involved 91 patients with advanced colorectal cancer. Treatment: The treatment consisted of two chemotherapy drugs – irinotecan (CPT-11, camptosar)... read more
64315.6 monthsMetastatic renal cell carcinoma5Biologic therapy, ImmunotherapyWake Forest UniversityUnited StatesJun 2004
Treatment Details: Patients: This Phase II trial involved 30 patients with metastatic renal cell carcinoma; 19 men and 11 women. The median age was 62. Seventeen patients had undergone a prior neph... read more
64415.5 monthsMetastatic hepatocellular (liver) or fibrolamellar carcinoma4Chemotherapy, ImmunotherapyThe University of Texas M. D. Anderson Cancer CenterUnited StatesFeb 2003
Treatment Details: Patients: This Phase II trial involved 43 patients. Thirty-four had hepatocellular carcinoma and nine had fibrolamellar hepatocellular carcinoma. All had metastatic disease (TNM... read more
64515.5 monthsMetastatic colorectal cancer4Chemotherapy, Biologic therapyCentre René GauducheauFranceApr 2014
Treatment Details: Patients: This phase 3 study involved metastatic colorectal cancer patients who were separated into four different groups based on treatment and their genetic status of the KRAS g... read more
64615.5 monthsPlatinum refractory or resistant ovarian cancer or resistant peritoneal cancer5Chemotherapy, Biologic therapyDepartments of Medical Oncology, MayoUnited StatesApr 2011
Treatment Details: Patients: This study involved 18 women with platinum refractory or resistant ovarian or peritoneal cancer. The median patient age was 66 years. All patients had previously been ... read more
64715.5 monthsMalignant peritoneal mesothelioma 5Chemotherapy, Radiation, SurgeryAzienda Ospedaliera-Università di PadovaItalyJan 2013
Treatment Details: Patients: This phase 2 study involved 54 malignant pleural mesothelioma patients who had not received prior treatment. The median patient age was 63 years and 87% were male. T... read more
64815.5 monthsMetastatic, castration-resistant prostate cancer5Chemotherapy, HormoneNational Cancer InstituteUnited StatesSep 2013
Treatment Details: Patients: This phase 2 study involved 23 metastatic castration-resistant prostate cancer patients who were previously treated with docetaxel-based chemotherapy. The median patien... read more
64915.4 monthsMelanoma4ImmunotherapyGustave Roussy Comprehensive Cancer CenterFranceOct 2013
Treatment Details: Patients: This phase 3 study involved 657 melanoma patients with a median age of 54 years; 54.3% were male. Treatment: Patients were given immunotherapy with a vaccine called ... read more
65015.4 monthsmetastatic breast cancer4ChemotherapyTexas OncologyUnited StatesAug 2005
Treatment Details: Patients: This Phase III study involved 449 women with advanced breast cancer, of whom 394 were assessed. All patients had previously received an anthracycline-containing chemoth... read more
Page 65 of 186 1 63 64 65 66 67 186